|
Despegar com Corp (NYSE: DESP) |
|
|
|
Despegar Com Corp Income Statement Quarterly
DESP
Select the Financial Report: |
Period: |
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2023) Q4 2023 |
0 Q3 2023 |
0 Q2 2023 |
0 Q1 2023 |
(Dec 31 2022) Q4 2022 |
Revenue From Contract With Customer Excluding Assessed Tax |
|
- |
- |
- |
|
Other Revenue |
|
- |
- |
- |
|
Total Revenue |
705.10 |
0.00 |
0.00 |
0.00 |
537.97 |
Cost of Revenue |
228.94 |
- |
- |
- |
182.90 |
Gross
Profit |
477.10 |
0.00 |
0.00 |
0.00 |
355.07 |
Selling, Administration, Marketing |
220.36 |
- |
- |
- |
165.15 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
109.13 |
- |
- |
- |
89.99 |
Impairment of Long-Lived Assets Held-for-use |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
82.43 |
- |
- |
- |
101.69 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
640.86 |
- |
- |
- |
539.73 |
Operating income/-loss
|
64.24 |
- |
- |
- |
-1.75 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss (Income) from Equity Method Investments |
-1.06 |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
37.69 |
- |
- |
- |
45.46 |
Total costs & expenses |
677.50 |
0.00 |
0.00 |
0.00 |
585.18 |
Income /-loss before income taxes |
27.61 |
0.00 |
0.00 |
0.00 |
-47.21 |
Income taxes expenses/-benefit |
3.12 |
- |
- |
- |
21.31 |
Income after income taxes |
24.49 |
0.00 |
0.00 |
0.00 |
-68.52 |
Net income/-loss
of other equity |
0.00 |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
24.49 |
0.00 |
0.00 |
0.00 |
-68.52 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
24.49 |
0.00 |
0.00 |
0.00 |
-68.52 |
Non-controlling interests |
- |
- |
- |
- |
- |
Preferred dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
24.49 |
0.00 |
0.00 |
0.00 |
-68.52 |
EBIT |
0.00 |
0.00 |
0.00 |
0.00 |
-47.21 |
EBITD |
0.00 |
0.00 |
0.00 |
0.00 |
-40.19 |
EBITDA |
0.00 |
0.00 |
0.00 |
0.00 |
-11.21 |
Per
Share (GAAP Quarterly, in $) |
(Dec 31 2023) Q4 2023 |
0 Q3 2023 |
0 Q2 2023 |
0 Q1 2023 |
(Dec 31 2022) Q4 2022 |
Basic EPS (excl. extra
items) |
-0.09 |
0.00 |
0.00 |
0.00 |
-1.28 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
-0.09 |
0.00 |
0.00 |
0.00 |
-1.28 |
Basic shares outstanding (Mill.
of Units) |
77.17 |
0.00 |
0.00 |
0.00 |
76.82 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
-0.09 |
0.00 |
0.00 |
0.00 |
-1.28 |
Diluted average shares (Mill.
of Units) |
77.17 |
77.17 |
77.17 |
77.17 |
76.82 |
Dividend per share |
- |
- |
- |
- |
- |
|
|